What is drug lag? The delay between when a drug is available in one country, to when it is available in other countries, with local regulatory approval used as the benchmark. Due to a significant body of work highlighting the costs and implications of this delay in access to innovative medicine, the global drug lag has decreased over time as local regulators rework their approval criteria to be more effective and efficient.
Here The Economist Intelligence Unit explains what is in the way of access to medicines:
We are running a series of infographics over the coming months in our monthly Healthcare newsletter. The EIU Healthcare newsletter provides you with the latest research, analysis and recommendations across the healthcare ecosystem. To sign up to the newsletter, please register using the button below.
